News

In mid-2018, nitrosamine content, also called NDMA, was found to go beyond the guidelines when it came to the daily intake limits of a hypertension medicine that is widely used and has potentially carcinogenic effects for patients. What thereafter...

On a mission so as to debut the life sciences companies on an international stage, Great Point Partners, the healthcare investment firm, is making a play in terms of a private German contract development and manufacturing organization, Lyocontract. Great Point...

Prefilled syringes have gone on to make up a decent portion in terms of injectable packaging segment in the past 10 years. As per an analysis done by GloblData, PFS went on to get 17% of the US FDA...

It is well to be noted that prefilled products, specifically prefilled biologics, happen to be a growing segment in the pharmaceutical sector. Prefilled syringes as well as pens offer detailed dosing, thereby decreasing the error risk in the process...

A new report rolled out by MarketsandMarkets has gone on to forecast that the injectable drug delivery market is going to be reaching almost 9% CAGR between 2024 and 2029. This market is expected to be valued at $1139 billion...

Worldwide pharmaceutical companies look to advance the development of molecules from the laboratory to the clinic and then market them as soon as possible. All this must go on to unfold sans sacrificing the quality of the product, efficiency...

It has indeed been a roller coaster ride for the biopharmaceutical sector ever since the pandemic-led surge in 2020. Since 2023, the resurgence when it comes to mergers and acquisitions has also gone on to signal a significant uptick...